FIELD: genetic engineering.
SUBSTANCE: present invention relates to genetic engineering and medicine, in particular to a gene-cell vesicular therapeutic drug for the treatment of multiple sclerosis and a method for the treatment of multiple sclerosis by transplantation of said drug by single intravenous administration. The preparation according to the invention consists of cytochalasin-induced B micro-vesicules of mesenchymal stromal cells from adipose tissue, previously genetically modified with a recombinant lentivirus containing the nucleotide sequence of the NGF nerve growth factor gene.
EFFECT: present invention makes it possible to reduce the area of foci of demyelination in the human central nervous system, the number of reactive astrocytes, the level of proinflammatory cytokines in the blood serum of patients with neurogenerative diseases and reduce neuroinflammation in general.
2 cl, 13 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
| APPLICATION OF 5'-METHYLTHIOADENOSINE (MTA) FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES AND/OR GRAFT REJECTION | 2005 |
|
RU2393866C2 |
| NEW TREATMENT OF MULTIPLE SCLEROSIS (MS) | 2011 |
|
RU2595861C2 |
| DRUG FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY AND A METHOD FOR ITS TREATMENT | 2021 |
|
RU2769577C1 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
| METHODS, PHARMACEUTICAL COMPOSITIONS AND PRODUCTS FOR THERAPEUTIC CELL INTRODUCTION INTO ANIMAL'S CENTRAL NERVOUS SYSTEM | 2008 |
|
RU2468818C2 |
| STEM CELL PREPARATION WITH REPROGRAMMED CELL SIGNALLING, METHOD FOR MAKING THIS PREPARATION AND APPLICATION THEREOF | 2008 |
|
RU2428475C2 |
| SPECIFIC ANTIBODIES TO ALPHA-ENOLASE AND METHOD OF USING IN IMMUNE DISEASES | 2014 |
|
RU2707812C1 |
| USING OPPOSITE CELL DIFFERENTIATION PROGRAMME (OCDP) FOR TREATING DEGENERATED ORGANS IN PATHOLOGICAL STATES | 2008 |
|
RU2528084C2 |
| RELEASE AND IDENTIFICATION OF T-CELLS | 2003 |
|
RU2327487C2 |
